Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigation of Tofacitinib PsA Initiators in the CorEvitas SpA Registry

NCT05195814 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05195814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05195814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigation of Tofacitinib PsA Initiators in the CorEvitas SpA Registry
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
November 15, 2021
Completion date
October 31, 2023
Enrollment
141 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis